Medicines in older people - review and rationalise
Clinical e-Audit for GPsStart now
- RACGP 40 (Category 1) QI&CPD points (QI activity)
- ACRRM 30 PRPD points
Older people experience a disproportionate number of medicine-related adverse events. GPs are often the first point of contact for most people aged 65 years and over, therefore GPs are best placed to review and rationalise medicine use for their patients.
Reflect on your management of 10 patients aged ≥ 75 years old using 5 or more medicines and prescribed at least one of the following:
- an antipsychotic medicine for behavioural and psychological symptoms of dementia OR
- a benzodiazepine for insomnia OR
- an opioid for chronic non-cancer pain
Participation in this activity will assist GPs to:
- Implement a systematic approach to review older people's medicines as recommended in current guidelines, in particular considering indication and adverse events
- Assess for risk factors in older people that may contribute to medicines-related problems
- Discuss the benefits of non-pharmacological therapies for your older patient
- Evaluate response to medicines and assess the need for ongoing therapy specifically for antipsychotic medicines, benzodiazepines and opioids
Participants will have access to
- Up-to-date clinical guidance: This activity will provide evidence-based information to update your knowledge and practical advice to provide to your patients.
- Expert commentary: An expert commentary will become available when at least 100 GPs have submitted their Initial data. The expert commentary will be provided by Professor David Le Couteur (Geriatric Medicine, Concord Clinical School, ANZAC Research Institute).
- Quality assurance in this practice and your privacy (poster)
- Your health records and NPS MedicineWise clinical e-audits (patient leaflet)
Frequently asked questions
CPD Points and Practice Incentives
This activity has been accredited for 40 (Category 1) points (QI activity) in the RACGP QI&CPD Program for the 2014–2016 triennium (activity ID number 1390).
This activity has been accredited for 30 PRPD points in the ACRRM PDP Program for the 2014–2016 triennium (code O1401NPMW).
This activity is recognised for the Practice Incentives Program Quality Prescribing Incentive (PIP QPI).